Tapestry, Inc. · TPR · FY2025 Q1 · Calendar Q4 2024
Tapestry raises FY2025 outlook as Coach momentum offsets deal uncertainty
The supplied analysis supports a constructive near-term operating thesis for Tapestry: Coach product momentum, younger-customer acquisition, international growth, and margin expansion are supporting the outlook. The main counterweight is execution and transaction risk around Capri, alongside uneven performance across brands and regions.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about TPR FY2025 Q1
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter, management's stance became more constructive: the current analysis describes a first-quarter beat, record gross margin, double-digit EPS growth, and a raised FY2025 outlook. The Capri situation also became more immediate, with an FTC preliminary injunction, an appeal, and a stated buyback contingency if the transaction fails.
Guidance delta
Management raised FY2025 guidance after a first-quarter beat; the supplied analysis does not provide the revised figures.
Key takeaways
- The quarter beat expectations, with record gross margin and double-digit EPS growth highlighted in the supplied analysis.
- Coach led through new products, higher AUR, and Gen Z customer acquisition.
- International performance was strong, especially in Europe and Greater China, while Kate Spade and Stuart Weitzman were mixed.
- The Capri transaction remains subject to legal uncertainty; management identified share buybacks as a priority if the deal fails.
Management priorities
- Expand Coach product lines and continue product innovation.
- Invest in digital, omnichannel capabilities, and purpose-driven marketing.
- Continue international expansion and selected store investments, including in China.
- Maintain disciplined capital allocation while organic growth remains the priority.
Follow TPR with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 25, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Buy | Buy | Maintain | Oct 20, 2026 |
| Raymond James | Outperform | Outperform | Maintain | Oct 16, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Aug 14, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Aug 14, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Aug 14, 2026 |
| BTIG | Buy | Buy | Maintain | Aug 14, 2026 |
| Bernstein | Market Perform | Market Perform | Maintain | Aug 14, 2026 |
| Barclays | Overweight | Overweight | Maintain | Aug 14, 2026 |
| Telsey Advisory Group | Outperform | Outperform | Maintain | Aug 6, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Aug 4, 2026 |
| Citigroup | Buy | Buy | Maintain | Apr 29, 2026 |
| Baird | Outperform | Outperform | Maintain | Apr 29, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Jan 30, 2026 |
| Jefferies | Hold | Buy | Downgrade | Jan 14, 2026 |
| B of A Securities | Hold | Buy | Downgrade | Jul 29, 2025 |
| Argus Research | Buy | Buy | Maintain | Jun 17, 2025 |
| Redburn Atlantic | Buy | Neutral | Upgrade | Feb 18, 2025 |
| Guggenheim | Buy | Buy | Maintain | Feb 7, 2025 |
| BMO Capital | Market Perform | Market Perform | Maintain | Nov 18, 2024 |
| TD Cowen | Hold | Buy | Downgrade | Oct 29, 2024 |
| OTR Global | Mixed | Positive | Downgrade | Apr 17, 2024 |
| Edward Jones | Hold | Buy | Downgrade | Aug 11, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Feb 10, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Aug 19, 2022 |
| Piper Sandler | Overweight | Overweight | Maintain | Nov 12, 2021 |
| Keybanc | Overweight | Overweight | Maintain | Feb 9, 2021 |
| Needham | Buy | Buy | Maintain | Feb 5, 2021 |
| HSBC | Buy | Buy | Maintain | Oct 15, 2020 |
| Deutsche Bank | Buy | Hold | Upgrade | Sep 16, 2020 |
| MKM Partners | Neutral | Neutral | Maintain | Aug 19, 2020 |
| CFRA | Buy | Buy | Maintain | Apr 30, 2020 |
| Piper Jaffray | Neutral | Overweight | Downgrade | Aug 16, 2019 |
| Oppenheimer | Perform | Outperform | Downgrade | Aug 16, 2019 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Jan 25, 2019 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Nov 14, 2018 |
| Canaccord Genuity | Buy | Buy | Maintain | Oct 31, 2018 |
| Buckingham Research | Buy | Buy | Maintain | Oct 31, 2018 |
| Buckingham | Buy | Buy | Maintain | Oct 31, 2018 |
| Loop Capital | Hold | Buy | Downgrade | Oct 15, 2018 |
| Bank of America | Buy | Buy | Maintain | Aug 15, 2018 |
Named analyst price targets
Upside is calculated against the persisted current price $110.37. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $200 | $115.87 | +81.2% | Oct 20, 2026 |
| Raymond James | Analyst unavailable | $140 | $119.77 | +26.8% | Oct 16, 2026 |
| Daiwa | Analyst unavailable | $140 | $129.02 | +26.8% | Aug 18, 2026 |
| Morgan Stanley | Analyst unavailable | $159 | $128.83 | +44.1% | Aug 14, 2026 |
| Bernstein | Analyst unavailable | $185 | $128.39 | +67.6% | Aug 14, 2026 |
| UBS | Jay Sole | $232 | $128.39 | +110.2% | Aug 14, 2026 |
| Barclays | Analyst unavailable | $185 | $128.39 | +67.6% | Aug 14, 2026 |
| Wells Fargo | Ike Boruchow | $160 | $128.39 | +45.0% | Aug 13, 2026 |
| Telsey Advisory | Dana Telsey | $175 | $160.86 | +58.6% | Aug 6, 2026 |
| Barclays | Analyst unavailable | $182 | $140.26 | +64.9% | Jul 16, 2026 |
| Morgan Stanley | Alex Straton | $164 | $144.12 | +48.6% | Jul 6, 2026 |
| UBS | Jay Sole | $230 | $149.2 | +108.4% | Jun 23, 2026 |
| Bernstein | Aneesha Sherman | $180 | $139.34 | +63.1% | Jun 2, 2026 |
| Evercore ISI | Analyst unavailable | $175 | $136.54 | +58.6% | May 8, 2026 |
| UBS | Analyst unavailable | $187 | $130.52 | +69.4% | May 8, 2026 |
| Robert W. Baird | Analyst unavailable | $165 | $143.84 | +49.5% | Apr 29, 2026 |
| BTIG | Analyst unavailable | $180 | $146.45 | +63.1% | Apr 24, 2026 |
| UBS | Analyst unavailable | $142 | $148.86 | +28.7% | Apr 23, 2026 |
| Raymond James | Analyst unavailable | $165 | $146.18 | +49.5% | Apr 23, 2026 |
| Argus Research | Kristina Ruggeri | $165 | $145.42 | +49.5% | Mar 12, 2026 |
| BNP Paribas | Analyst unavailable | $176 | $152.66 | +59.5% | Feb 13, 2026 |
| UBS | Analyst unavailable | $141 | $153.28 | +27.8% | Feb 9, 2026 |
| BTIG | Analyst unavailable | $175 | $152.1 | +58.6% | Feb 8, 2026 |
| Robert W. Baird | Analyst unavailable | $160 | $149.48 | +45.0% | Feb 6, 2026 |
| Goldman Sachs | Brooke Roach | $166 | $150.48 | +50.4% | Feb 6, 2026 |
| Bernstein | Analyst unavailable | $170 | $150.48 | +54.0% | Feb 6, 2026 |
| Wells Fargo | Analyst unavailable | $165 | $143.19 | +49.5% | Feb 6, 2026 |
| Barclays | Adrienne Yih | $179 | $143.19 | +62.2% | Feb 6, 2026 |
| Evercore ISI | Michael Binetti | $150 | $128.49 | +35.9% | Feb 3, 2026 |
| Goldman Sachs | Brooke Roach | $146 | $127.33 | +32.3% | Jan 30, 2026 |
| Jefferies | Analyst unavailable | $138 | $134.38 | +25.0% | Jan 14, 2026 |
| Barclays | Adrienne Yih | $155 | $134.35 | +40.4% | Jan 12, 2026 |
| UBS | Jay Sole | $123 | $130.97 | +11.4% | Jan 8, 2026 |
| Bernstein | Analyst unavailable | $150 | $131.62 | +35.9% | Jan 6, 2026 |
| Barclays | Adrienne Yih | $154 | $128.53 | +39.5% | Jan 6, 2026 |
| Telsey Advisory | Analyst unavailable | $150 | $122.56 | +35.9% | Dec 17, 2025 |
| Robert W. Baird | Mark Altschwager | $140 | $123.1 | +26.8% | Dec 17, 2025 |
| Jefferies | Ashley Helgans | $142 | $123.52 | +28.7% | Dec 12, 2025 |
| Bernstein | Aneesha Sherman | $115 | $103.24 | +4.2% | Nov 7, 2025 |
| Evercore ISI | Analyst unavailable | $129 | $107.2 | +16.9% | Nov 3, 2025 |
| Robert W. Baird | Analyst unavailable | $130 | $113.11 | +17.8% | Oct 29, 2025 |
| Wells Fargo | Analyst unavailable | $135 | $114.71 | +22.3% | Oct 27, 2025 |
| Jefferies | Ashley Helgans | $135 | $115.34 | +22.3% | Oct 23, 2025 |
| Raymond James | Analyst unavailable | $130 | $117.36 | +17.8% | Oct 21, 2025 |
| BTIG | Analyst unavailable | $140 | $116.26 | +26.8% | Oct 14, 2025 |
| Bernstein | Aneesha Sherman | $112 | $97.6 | +1.5% | Aug 15, 2025 |
| Goldman Sachs | Analyst unavailable | $84 | $64.92 | -23.9% | Apr 22, 2025 |
| Telsey Advisory | Dana Telsey | $83 | $73.53 | -24.8% | Feb 3, 2025 |
| UBS | Jay Sole | $70 | $67.15 | -36.6% | Jan 10, 2025 |
| Bernstein | Aneesha Sherman | $78 | $67.36 | -29.3% | Jan 7, 2025 |
| Jefferies | Ashley Helgans | $80 | $62.08 | -27.5% | Dec 19, 2024 |
| Guggenheim | Robert Drbul | $70 | $57.24 | -36.6% | Nov 15, 2024 |
| Robert W. Baird | Mark Altschwager | $64 | $57.32 | -42.0% | Nov 15, 2024 |
| Telsey Advisory | Dana Telsey | $58 | $50.67 | -47.4% | Nov 8, 2024 |
| Citigroup | Paul Lejuez | $55 | $50.47 | -50.2% | Oct 29, 2024 |
| BMO Capital | Simeon Siegel | $44 | $40.48 | -60.1% | Aug 16, 2024 |
| CFRA | Zachary Warring | $47 | $40.37 | -57.4% | May 9, 2024 |
| Wells Fargo | Ike Boruchow | $60 | $40.9 | -45.6% | Apr 18, 2024 |
| Evercore ISI | Michael Binetti | $50 | $40.01 | -54.7% | Feb 5, 2024 |
| Guggenheim | Robert Drbul | $60 | $27.46 | -45.6% | Nov 9, 2023 |
| UBS | Kate Spade | $39 | $31.71 | -64.7% | Sep 7, 2023 |
| Telsey Advisory | Dana Telsey | $54 | $44.54 | -51.1% | Feb 10, 2023 |
| UBS | Jay Sole | $31 | $32.51 | -71.9% | Jul 26, 2022 |
| Jefferies | Ashley Helgans | $45 | $31.6 | -59.2% | Jun 15, 2022 |
| Telsey Advisory | Kate Spade | $46 | $32.07 | -58.3% | May 13, 2022 |
| UBS | Jay Sole | $36 | $31.86 | -67.4% | May 13, 2022 |
| Barclays | Analyst unavailable | $53 | $35.32 | -52.0% | Apr 19, 2022 |
| Bernstein | Aneesha Sherman | $62 | $38.41 | -43.8% | Mar 18, 2022 |
| J.P. Morgan | Matthew Boss | $56 | $40.47 | -49.3% | Feb 10, 2022 |
| BTIG | Camilo Lyon | $63 | $40.46 | -42.9% | Feb 9, 2022 |
| Argus Research | Kristina Ruggeri | $54 | $45.42 | -51.1% | Nov 19, 2021 |
| Cowen & Co. | Oliver Chen | $56 | $45.42 | -49.3% | Nov 19, 2021 |
| Morgan Stanley | Kimberly Greenberger | $43 | $44.34 | -61.0% | Nov 15, 2021 |
| BMO Capital | Simeon Siegel | $50 | $44.96 | -54.7% | Nov 12, 2021 |
| Piper Sandler | Erinn Murphy | $63 | $44.96 | -42.9% | Nov 12, 2021 |
| Goldman Sachs | Brooke Roach | $49 | $44.96 | -55.6% | Nov 12, 2021 |
| Jefferies | Randal Konik | $50 | $45.6 | -54.7% | Nov 11, 2021 |
| Credit Suisse | Michael Binetti | $67 | $48.21 | -39.3% | May 7, 2021 |
Track every rating change on TPR the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationTapestry, Inc. is a prominent global fashion house specializing in premium accessories and distinct lifestyle brands. It operates internationally, serving customers across the United States, Japan, Greater China, and other markets worldwide. The company's diverse portfolio is structured around three well-known brands: Coach, Kate Spade, and Stuart Weitzman. Tapestry offers an extensive product range catering to women, men, and even includes items for children and home goods. For women, this encompasses a vast selection of luxury accessories, including various handbag styles such as wallets, wristlets, and cosmetic cases, alongside unique novelty items like travel accessories, sketchbooks, and keychains. The collection further features footwear, eyewear, fine jewelry (bracelets, necklaces, rings, and earrings), fragrances, watches, and seasonal apparel, which covers outerwear, ready-to-wear collections, and cold-weather essentials like gloves, scarves, and hats.…
Historical context
All TPR earningsConsumer Cyclical peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| DECK Deckers Outdoor Corporation | FY2027 Q2 · Calendar Q4 2026 | +13.4% | -0.2% | Deckers raises FY2027 outlook as HOKA and UGG drive growth |
| TSCO Tractor Supply Company | FY2026 Q3 · Calendar Q4 2026 | +5.3% | +6.2% | Tractor Supply Q3: Pet and Digital Momentum Supports Margin Plan |
| PHM PulteGroup, Inc. | FY2026 Q3 · Calendar Q4 2026 | -4.5% | +5.8% | PulteGroup Holds Guidance as Buyer Traffic Slows |
| PKG Packaging Corporation of America | FY2026 Q3 · Calendar Q4 2026 | +3.8% | +4.2% | PCA beats Q3 expectations as Greif synergies offset cost pressure |
Latest beats and misses
Who reports nextBeat on EPS
- FCNCAFY2026 Q3 · October 23, 2026+19.9% EPS+8.2% move
- FCNCNFY2026 Q3 · October 23, 2026+19.9% EPS+0.2% move
- FCNCOFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
- FCNCPFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
- RDYFY2027 Q2 · October 23, 2026+24.0% EPS-0.2% move
- SLBFY2026 Q3 · October 23, 2026+3.7% EPS+7.1% move
Missed on EPS
- INFYFY2027 Q2 · October 23, 2026-4.8% EPS-6.6% move
- BBDFY2026 Q3 · October 22, 2026-7.7% EPS+3.0% move
- SNAFY2026 Q3 · October 22, 2026-5.9% EPS-3.4% move
- SPOTFY2026 Q3 · October 22, 2026-11.6% EPS+11.1% move
- VRSNFY2026 Q3 · October 22, 2026-2.0% EPS-0.9% move
- HBANMFY2026 Q3 · October 22, 2026-5.3% EPS+0.5% move
Get the TPR recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-11-10T18:38:36.707185+00:00
- Polygon adjusted daily market bars · 2026-10-25T01:20:40.665228+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-25T01:20:40.662467+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-25. For educational purposes only; not investment advice.